San Joaquin Valley Fever, now called “Valley Fever” for short, was named because of an outbreak among farm workers in the well known San Joaquin Valley of California. The condition is caused by inhaling dust or dirt contaminated with a fungus called “Coccidiodes immitis.” The fungus is inhaled into the lung where it may simply cause a low grade chronic cough and calcification (mineralization) of local lymph nodes or, if one’s immune system is weak, it can cause pneumonia or even disseminate throughout the body.
The fungus lives only in one area: the Lower Sonoran life zone. This area includes the southwest United States, Mexico and Central America as well as parts of South America. In these places, soil is sandy and alkaline. There is little rainfall. Summer is hot and Winter is cold. Fungal spores (called “arthroconidia”) are released from the ground after a rainfall and are carried by the wind. Earthquakes or high winds or even crop harvesting have led to outbreaks of this infection as both conditions stir up fungal spores. Once the spores are in the air, they can be inhaled and set up infection.
It has been estimated that 60% of animals and people that become infected with this fungus, never get sick. It is only when antibodies indicating past infection show up on a blood test that infection is discovered.
But the other 40% do get sick. It only takes 1-3 weeks from the inhalation of fungal spores before coughing starts. Fever, weight loss, and appetite loss accompany the cough, which can be dry or productive. If the fungus escapes the lung and travels out elsewhere in the body, the infection is said to have “disseminated” and prognosis is much worse. On the average, several months pass between the initial cough (which may be so mild as to have gone undetected) and signs in another organ system. There is an order by which the fungus disseminates in that in appears in certain organs before others. After the lung, the fungus spreads to bone, then eyes, heart, testicles, brain, spinal cord, and abdominal organs. In cats, the pattern is a bit different with the usual disease picture being draining skin lesions with fever, weight loss and poor appetite. The respiratory phase is rarely noted in feline patients.
An animal or person who is sick is not contagious; infection is only through inhalation of a fungal spore released from dirt but only a few spores are necessary for infection to occur.
There are several diagnostics that can be helpful with this condition.
The patient with a cough is likely to have his chest radiographed. Findings will not be specific to Valley Fever; large lymph nodes, lung infiltration will likely be found. The point is to rule out other conditions that are more readily identifiable on radiographs such as heart disease, tracheal collapse, or more localized forms of pneumonia.
If some sort of tracheal wash or lavage is performed (where samples of lung fluid are collected for analysis), it is possible to actually capture some fungal spores. If this occurs, the diagnosis is confirmed, as Coccidiodes immitis has a fairly characteristic large size and appearance.
Blood testing is by far the least invasive way of reaching a diagnosis of Valley Fever. Antibodies against the fungus are measured in a blood sample using one or even several different methods (tube precipitin, complement fixation, latex agglutination, gel immunodiffusion, or enzyme linked immunoassay). As mentioned, many patients are exposed to this fungus and do not get sick. These patients will absolutely have positive antibody tests so it is important not to treat an animal with a positive antibody level (also called an antibody “titer”) and no history of symptoms of any kind.
A general rule with any fungal infection is that it takes a long time to clear. Valley Fever is no different and a year of medication administration is fairly common. Treatment continues until the clinical signs have resolved, the radiographs look normal, and the antibody level has stabilized (note antibody levels may never fully drop to zero). Ketoconazole, itraconazole, and fluconazole are the usual drugs for this condition. Monitoring liver enzymes is important with all of these, particularly since such long treatment courses are common.
Lufenuron, active ingredient in the flea control product “Program,” was developed to inhibit the development of chitin (the crunchy exterior material of the insect body). The idea was that a flea larva who had fed upon blood pellets (“flea dirt”) from a pet treated with oral lufenuron, would be unable to properly pupate into an adult flea. It turns out that the shell of Coccidiodes immitis is also rich in chitin and that lufenuron at special doses may be helpful in clearing this infection. This is still an experimental use but it may be worthwhile to ask your veterinarian about this product.
If the disease is limited to the lung, prognosis is felt to be good. The most severe form of infection appears to involve bone and when multiple bones are infected, complete recovery is unlikely unless amputation is possible. Eye involvement is painful and very difficult to clear short of removing the eye (“enucleation”). Obviously, a patient with any internal fungal infection should avoid immunosuppressive drugs for other conditions as their use could lead to a disastrous fungal dissemination.
Page last reviewed: 3/20/2011